TCW Group’s BeOne Medicines Ltd ONC Stock Holding History

TCW Group’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-13,177	Closed	-$386K	–	696
2016 Q1	$386K	Buy	+13,177	New	+$373K	﹤0.01%	652

Other funds holding ONC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCW Group's ONC Position: Q2 2016 in Review

TCW Group sold out of BeOne Medicines Ltd (ONC) in Q2 2016, closing a stake of 13,177 shares — an estimated $386K sold.

TCW Group first reported a position in ONC in Q1 2016 and held it in 1 quarter. The position peaked at $386K in Q1 2016. 39 funds tracked by Wall St. Rank hold ONC as of Q2 2016.

TCW Group reported no remaining BeOne Medicines Ltd position as of Q2 2016 after selling out during the quarter.
TCW Group sold 13,177 BeOne Medicines Ltd shares in Q2 2016, an estimated $386K.
TCW Group first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 1 quarter.
TCW Group's BeOne Medicines Ltd position peaked at $386K in Q1 2016.
39 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2016.

Based on TCW Group's 13F filing for Q2 2016, filed 12 Aug 2016.